Pablo Iribarren Selected Research

Formyl Peptide Receptors (Formyl Peptide Receptor)

7/2007	Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.
2/2007	Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand.
2/2006	Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.
12/2005	CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2.
11/2005	IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia.
1/2005	Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.
10/2004	Silencing the formylpeptide receptor FPR by short-interfering RNA.
7/2004	TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways.
7/2004	Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor.
11/2003	IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Iribarren Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 07/2007 - 11/2003
8	Inflammation (Inflammations) 01/2019 - 01/2002
7	Neoplasms (Cancer) 01/2014 - 01/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 02/2004
3	Infections 10/2007 - 01/2002
3	Glioma (Gliomas) 04/2006 - 10/2004
2	Neuroinflammatory Diseases 04/2022 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 02/2007 - 07/2004
2	Glioblastoma (Glioblastoma Multiforme) 04/2006 - 06/2005
2	Leukemia 10/2004 - 07/2004
1	Splenomegaly 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Encephalitis (Encephalitis, Rasmussen) 09/2011
1	Bacterial Infections (Bacterial Infection) 02/2006
1	Infertility (Sterility) 09/2004
1	Virus Diseases (Viral Diseases) 01/2003

Drug/Important Bio-Agent (IBA)

10	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2007 - 11/2003
9	Peptides (Polypeptides)IBA 07/2007 - 11/2003
8	Amyloid beta-PeptidesIBA 07/2007 - 11/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2004
5	Chemotactic FactorsIBA 02/2006 - 01/2002
4	CytokinesIBA 04/2022 - 02/2007
4	GTP-Binding Proteins (G-Protein)IBA 02/2006 - 02/2004
3	Interleukin-12 (IL 12)IBA 04/2022 - 07/2009
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2006 - 04/2004
2	ChemokinesIBA 01/2017 - 04/2004
2	Small Interfering RNA (siRNA)IBA 06/2005 - 10/2004
2	LigandsIBA 02/2004 - 02/2004
1	Interleukin-18 (Interleukin 18)IBA 04/2022
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	SynucleinsIBA 01/2019
1	fludarabineIBA 01/2019
1	Peptidoglycan (Murein)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 09/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2007
1	CD40 Ligand (CD40L)IBA 02/2007
1	N-Formylmethionine Leucyl-PhenylalanineIBA 04/2006
1	Masoprocol (Actinex)FDA Link 04/2006
1	VimentinIBA 04/2006
1	Lipoxygenase InhibitorsIBA 04/2006
1	nordyIBA 04/2006
1	AcidsIBA 02/2006
1	Toll-Like Receptor 2IBA 02/2006
1	Amyloid (Amyloid Fibrils)IBA 11/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2005
1	Biological ProductsIBA 06/2005
1	A-factor (Streptomyces)IBA 06/2005
1	MMK-1 peptideIBA 02/2005
1	Amino Acids FDA Link 02/2005
1	CalciumIBA 09/2004
1	Progesterone FDA LinkGeneric 09/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2004
1	peptide AIBA 07/2004
1	Pharmaceutical PreparationsIBA 02/2004
1	Cyclic ADP-Ribose (cADPR)IBA 02/2004
1	Superoxides (Superoxide)IBA 02/2004
1	Chemokine ReceptorsIBA 01/2003

Therapy/Procedure

1	Immunomodulation 04/2022
1	Immunotherapy 01/2014